BRIEF-Synthetic Biologics Provides Update On Syn-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical Trial
BRIEF-Synthetic Biologics Provides Update On Syn-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical Trial
簡介-合成生物製品提供Syn-020腸道鹼性磷酸酶1期單劑量遞增臨牀試驗的最新進展
June 29 (Reuters) - Synthetic Biologics Inc :
* SYNTHETIC BIOLOGICS PROVIDES UPDATE ON SYN-020 INTESTINAL ALKALINE PHOSPHATASE PHASE 1 SINGLE-ASCENDING DOSE CLINICAL TRIAL
* SYNTHETIC BIOLOGICS INC - ANALYSES OF PRELIMINARY DATA DEMONSTRATED THAT SYN-020 MAINTAINED A FAVORABLE SAFETY PROFILE, WAS WELL TOLERATED
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透6月29日電-合成生物製品公司：
*合成生物製品提供SYN-020腸道鹼性磷酸酶1期單次遞增劑量臨牀試驗的最新情況
*合成生物製品公司-對初步數據的分析表明，SYN-020保持了良好的安全性，耐受性良好
Eikon的源文本：進一步的公司報道：
(Reurs.Briefs@thomsonreurs.com；)